AKT1 and endometrial cancer: It has also been recently reported that in vivo models of endometrial cancer exposed to other endocrine-disrupting chemicals such as diethylstilbestrol (DES) aberrantly activated the WNT/β-catenin and TGFβ/PDGFRα-related PI3K/AKT signaling pathways [86].